On November 17, 2018, the Left Heart Ear Forum of the World Structural Heart Disease Interventional Therapy Conference was held in Frankfurt, Germany, where global structural heart disease medical experts gathered. Professor Zhu Mengyun from the Heart Center of Shanghai Tenth People's Hospital affiliated with Tongji University, who was deeply involved in the clinical trial research of Lefear left atrial appendage occluder of Pulse Medical Company, delivered a keynote speech at the World Structural Heart Disease Intervention Treatment Conference on left atrial appendage and introduced the Lefear left atrial appendage occluder product of Pulse Medical Company to the conference.
Through the conference review, Lefear left atrial appendage occluder was awarded the "Best Innovative Product of the Competition".